Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis

FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis

Meda launches EDLUAR in the U.S.

Meda launches EDLUAR in the U.S.

DOR's Phase 1/2 clinical trial for prevention of radiation enteritis receives NIH grant

DOR's Phase 1/2 clinical trial for prevention of radiation enteritis receives NIH grant

Third human clinical trial of LigoCyte's norovirus vaccine started

Third human clinical trial of LigoCyte's norovirus vaccine started

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Millennium's sNDA to be reviewed by the FDA

Millennium's sNDA to be reviewed by the FDA

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules

QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

Study reveals poor body satisfaction and increased risk of disordered weight control behaviors among 10 to 11 year old children

Study reveals poor body satisfaction and increased risk of disordered weight control behaviors among 10 to 11 year old children

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

Nutra Pharma launches Cobroxin for chronic pain relief

Nutra Pharma launches Cobroxin for chronic pain relief

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.